Immunic, Inc. (IMUX) Discusses R&D Advances and Future Directions in Relapsing Multiple Sclerosis Transcript

Immunic, Inc. (IMUX) Discusses R&D Advances and Future Directions in Relapsing Multiple Sclerosis September 9, 2026 11:00 AM EDTCompany...

Continue in Briflio to read, react, comment, and share.